+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 70Years
All Genders
Healthy Volunteers
ID07643155

Evaluating the Pharmacokinetics and Safety of a Single 80 mcg Dose of Treprostinil Palmitil Inhalation Powder in Adults With Normal and Impaired Liver Function

Led by Insmed Incorporated · Updated on 2026-10-27

30

Participants Needed

4

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how different levels of liver impairment affect the way the body processes treprostinil palmitil TP and treprostinil TRE after a single dose of 80 micrograms of treprostinil palmitil inhalation powder TPIP. The study compares participants with normal liver function to those with mild, moderate, or severe hepatic impairment. This research is a Phase 1 trial focused on understanding the pharmacokinetics and safety of TPIP in these groups. Participants are divided into four groups based on liver function healthy individuals with normal hepatic function, and those with mild, moderate, or severe hepatic impairment as classified by the Child-Pugh score. Each participant receives a single dose of TPIP via oral inhalation using a dry powder inhaler device on Day 1. The study uses a parallel design without randomization or blinding. During the study, participants undergo blood sampling before dosing and at multiple time points up to Day 3 to measure drug concentration, clearance, half-life, and other pharmacokinetic parameters. Safety is monitored by recording adverse events up to Day 7. Participants also undergo medical history reviews, physical exams, ECG, vital signs, laboratory tests, and drug and alcohol screenings to ensure eligibility and safety. The total duration of participation covers screening through at least 7 days after dosing.

CONDITIONS

Brief Title

A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Research Team

I

Insmed Medical Information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here